Prostamax 20 mg – 10 vials

Prostamax (also known as KEDP) is a synthetic tetrapeptide research compound with the amino acid sequence Lys-Glu-Asp-Pro (lysine–glutamic acid–aspartic acid–proline), developed as a Khavinson-style bioregulator targeting prostate tissue. It functions as an epigenetic regulator that interacts with promoter regions and chromatin structure in prostatic epithelial cells and associated tissues, promoting complementary DNA-peptide interactions to normalize gene expression, modulate chromatin decondensation (e.g., reducing heterochromatin condensation in aging models), and support cellular repair processes. In preclinical models (including rat models of chronic aseptic prostatitis, prostate tissue explants, lymphocyte cultures, and aging studies), Prostamax demonstrates prostatotropic effects by reducing signs of chronic inflammation (e.g., glandular swelling, vascular hyperemia, lymphoid infiltration), mitigating fibrosis progression, preserving tissue architecture, stimulating reparative mechanisms (e.g., via enhanced proliferative activity and ribosomal biogenesis), and exhibiting geroprotective actions such as heterochromatin deheterochromatinization to reactivate age-repressed genes. It may also influence broader immune modulation (e.g., in lymphocytes) and anti-inflammatory pathways without notable hormonal disruption. Compared to natural prostate extracts, its ultrashort structure confers high stability, bioavailability, and targeted epigenetic modulation with minimal side effects in research settings. Prostamax is utilized in research to investigate mechanisms of prostate homeostasis, epigenetic control of glandular gene expression, age-related prostatic changes (e.g., benign prostatic hyperplasia models, immunosenescence in reproductive tissues), protective strategies against chronic prostatitis and inflammatory complications, preventive approaches for age-associated urogenital decline, and the roles of short peptides in chromatin remodeling, cellular resilience, tissue regeneration, and longevity in prostate and related endocrine systems